139 related articles for article (PubMed ID: 1590532)
1. Amniotic tissue transplantation: clinical and biochemical evaluations for some lysosomal storage diseases.
Sakuragawa N; Yoshikawa H; Sasaki M
Brain Dev; 1992 Jan; 14(1):7-11. PubMed ID: 1590532
[TBL] [Abstract][Full Text] [Related]
2. A therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases.
Yeager AM; Singer HS; Buck JR; Matalon R; Brennan S; O'Toole SO; Moser HW
Am J Med Genet; 1985 Oct; 22(2):347-55. PubMed ID: 3931477
[TBL] [Abstract][Full Text] [Related]
3. Genetic errors and enzyme replacement strategies.
Brady RO
Res Publ Assoc Res Nerv Ment Dis; 1983; 60():181-93. PubMed ID: 6130585
[No Abstract] [Full Text] [Related]
4. What can cell biology tell us about heterogeneity in lysosomal storage diseases?
Gieselmann V
Acta Paediatr Suppl; 2005 Mar; 94(447):80-6; discussion 79. PubMed ID: 15895717
[TBL] [Abstract][Full Text] [Related]
5. [Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases].
Maaswinkel-Mooij PD; Poorthuis BJ; Hoogerbrugge PM; Brouwer OF; Vossen JM
Ned Tijdschr Geneeskd; 1998 Jan; 142(4):169-74. PubMed ID: 9557021
[TBL] [Abstract][Full Text] [Related]
6. [Recent advances in the diagnosis and treatment of lysosomal storage diseases].
Wu XR; Bao XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):440-4. PubMed ID: 16086072
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation.
Hoogerbrugge PM; Brouwer OF; Bordigoni P; Ringden O; Kapaun P; Ortega JJ; O'Meara A; Cornu G; Souillet G; Frappaz D
Lancet; 1995 Jun; 345(8962):1398-402. PubMed ID: 7760610
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases.
Krivit W
Springer Semin Immunopathol; 2004 Nov; 26(1-2):119-32. PubMed ID: 15452666
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
Inui K; Wenger DA
J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
[TBL] [Abstract][Full Text] [Related]
12. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases.
Martin PL; Carter SL; Kernan NA; Sahdev I; Wall D; Pietryga D; Wagner JE; Kurtzberg J
Biol Blood Marrow Transplant; 2006 Feb; 12(2):184-94. PubMed ID: 16443516
[TBL] [Abstract][Full Text] [Related]
13. New therapeutic prospects for the glycosphingolipid lysosomal storage diseases.
Platt FM; Butters TD
Biochem Pharmacol; 1998 Aug; 56(4):421-30. PubMed ID: 9763217
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of patients with lysosomal storage diseases].
Tylki-Szymańska A
Pol Tyg Lek; 1992 May 18-25; 47(20-21):450-2. PubMed ID: 1437765
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and prevention of lysosomal storage diseases in Russia.
Krasnopolskaya KD; Mirenburg TV; Aronovich EL; Lebedeva TV; Odinokova ON; Demina NA; Kozlova VM; Kuznetsov MI
J Inherit Metab Dis; 1993; 16(6):994-1002. PubMed ID: 8127076
[TBL] [Abstract][Full Text] [Related]
16. Current status of treatment in storage disorders.
Nadler HL
Birth Defects Orig Artic Ser; 1976; 12(6):177-88. PubMed ID: 10023
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal disorders associated with leukoencephalopathy.
Renaud DL
Semin Neurol; 2012 Feb; 32(1):51-4. PubMed ID: 22422206
[TBL] [Abstract][Full Text] [Related]
18. Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases.
Jakóbkiewicz-Banecka J; Wegrzyn A; Wegrzyn G
J Appl Genet; 2007; 48(4):383-8. PubMed ID: 17998597
[TBL] [Abstract][Full Text] [Related]
19. Lipidomics in diagnosis of lipidoses.
Wolf C; Quinn PJ
Subcell Biochem; 2008; 49():567-88. PubMed ID: 18751927
[TBL] [Abstract][Full Text] [Related]
20. Amniotic tissue transplantation as a trial of treatment in some lysosomal storage diseases.
Tylki-Szymańska A; Maciejko D; Kidawa M; Jabłońska-Budaj U; Czartoryska B
J Inherit Metab Dis; 1985; 8(3):101-4. PubMed ID: 3939584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
